Completed NCT00696813
This study is completed in Canada, in Czechia, in Denmark, .... It focuses on Schizophrenia.
Multiple locations, including Victoria Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. Over 18 Years
Countries Canada, Czechia, Denmark, ...
Sponsor Janssen-Cilag International NV
Condition Schizophrenia Terminated NCT00748566
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Calgary Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries Canada
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Completed NCT01432444
This study is completed in the United States and in Canada. It focuses on Schizophrenia.
Multiple locations, including Dothan Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Canada
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Terminated NCT01454453
This summary needs review. Please check the official study record and contact the research team for details.
In London Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 60 Years to 95 Years
Countries United Kingdom
Sponsor Institute of Psychiatry, London
Condition Schizophrenia Completed NCT03451734
This summary needs review. Please check the official study record and contact the research team for details.
In Changsha Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 17 Years to 65 Years
Countries China
Sponsor Central South University
Condition Schizophrenia Completed NCT00761579
This study is completed in South Korea. It focuses on Schizophrenia.
Multiple locations, including Busan Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries South Korea
Sponsor Janssen Korea, Ltd., Korea
Condition Schizophrenia Completed NCT02087579
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Depression, ... Drug From 18 Years to 70 Years
Countries United States, Belgium, Argentina, ...
Sponsor Janssen Research & Development, LLC
Condition Schizophrenia, Depression, ... Completed NCT01575912
This summary needs review. Please check the official study record and contact the research team for details.
In Limoges Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Depression Observational From 18 Years to 60 Years
Countries France
Sponsor Centre Hospitalier Esquirol
Condition Schizophrenia, Depression Completed NCT03527914
This summary needs review. Please check the official study record and contact the research team for details.
In Ottawa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 4 Years to 18 Years
Countries Canada
Sponsor Children's Hospital of Eastern Ontario
Condition Schizophrenia Completed NCT01133587
This summary needs review. Please check the official study record and contact the research team for details.
In Trondheim Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Behavioral Over 18 Years
Countries Norway
Sponsor St. Olavs Hospital
Condition Schizophrenia, Bipolarity Completed NCT00324051
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Rio de Janeiro Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Brazil, Romania, Türkiye
Sponsor Eli Lilly and Company
Condition Schizophrenia Completed NCT01914393
This study is completed in the United States, in France, in Bulgaria, .... It focuses on Schizophrenia.
Multiple locations, including Dothan Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity, ... Drug From 6 Years to 17 Years
Countries United States, France, Bulgaria, ...
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia, Bipolarity, ...